| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 1.85e-08 | 15 | 40 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 2.86e-06 | 112 | 40 | 5 | GO:0090079 | |
| GeneOntologyMolecularFunction | nicotinic acid receptor activity | 3.91e-06 | 2 | 40 | 2 | GO:0070553 | |
| GeneOntologyMolecularFunction | mRNA binding | 5.87e-05 | 694 | 40 | 8 | GO:0003729 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 2.15e-04 | 276 | 40 | 5 | GO:0003730 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 8.81e-04 | 22 | 40 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 8.81e-04 | 22 | 40 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.33e-03 | 27 | 40 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | translation regulator activity | 1.82e-03 | 443 | 40 | 5 | GO:0045182 | |
| GeneOntologyBiologicalProcess | female meiosis II | 1.81e-10 | 6 | 40 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.81e-10 | 6 | 40 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.81e-10 | 6 | 40 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 1.35e-09 | 26 | 40 | 5 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 8.82e-09 | 37 | 40 | 5 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 2.44e-08 | 45 | 40 | 5 | GO:0040020 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 2.78e-07 | 29 | 40 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 3.31e-07 | 75 | 40 | 5 | GO:0051785 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 3.67e-07 | 31 | 40 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 3.78e-07 | 77 | 40 | 5 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 5.18e-07 | 82 | 40 | 5 | GO:0051445 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 6.96e-07 | 87 | 40 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 7.37e-07 | 88 | 40 | 5 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 8.71e-07 | 91 | 40 | 5 | GO:0006446 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.16e-06 | 418 | 40 | 8 | GO:0009895 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 1.46e-06 | 101 | 40 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 2.04e-06 | 47 | 40 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.78e-06 | 115 | 40 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 3.07e-06 | 52 | 40 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 3.16e-06 | 118 | 40 | 5 | GO:2000243 | |
| GeneOntologyBiologicalProcess | translational initiation | 5.47e-06 | 132 | 40 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.05e-05 | 151 | 40 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | regulation of nuclear division | 1.98e-05 | 172 | 40 | 5 | GO:0051783 | |
| GeneOntologyBiologicalProcess | positive regulation of adiponectin secretion | 2.19e-05 | 4 | 40 | 2 | GO:0070165 | |
| GeneOntologyBiologicalProcess | oocyte development | 4.00e-05 | 99 | 40 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | regulation of translation | 4.07e-05 | 494 | 40 | 7 | GO:0006417 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 4.67e-05 | 103 | 40 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 9.66e-05 | 240 | 40 | 5 | GO:0140013 | |
| GeneOntologyBiologicalProcess | adiponectin secretion | 1.02e-04 | 8 | 40 | 2 | GO:0070162 | |
| GeneOntologyBiologicalProcess | regulation of adiponectin secretion | 1.02e-04 | 8 | 40 | 2 | GO:0070163 | |
| GeneOntologyBiologicalProcess | regulation of reproductive process | 1.19e-04 | 251 | 40 | 5 | GO:2000241 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 1.62e-04 | 268 | 40 | 5 | GO:1903046 | |
| GeneOntologyBiologicalProcess | oogenesis | 2.33e-04 | 156 | 40 | 4 | GO:0048477 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 2.41e-04 | 292 | 40 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 3.04e-04 | 307 | 40 | 5 | GO:0090068 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 3.08e-04 | 308 | 40 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 3.13e-04 | 309 | 40 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 3.32e-04 | 313 | 40 | 5 | GO:0098742 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.63e-04 | 187 | 40 | 4 | GO:0007156 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 5.52e-04 | 350 | 40 | 5 | GO:0051321 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 5.82e-04 | 354 | 40 | 5 | GO:0071695 | |
| GeneOntologyBiologicalProcess | negative regulation of interferon-beta production | 6.82e-04 | 20 | 40 | 2 | GO:0032688 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 7.36e-04 | 373 | 40 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | female gamete generation | 8.96e-04 | 223 | 40 | 4 | GO:0007292 | |
| GeneOntologyBiologicalProcess | translation | 9.32e-04 | 824 | 40 | 7 | GO:0006412 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | 1.09e-03 | 407 | 40 | 5 | GO:0045787 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 1.25e-03 | 27 | 40 | 2 | GO:1905874 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 1.42e-03 | 432 | 40 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 1.44e-03 | 1153 | 40 | 8 | GO:0010608 | |
| GeneOntologyBiologicalProcess | developmental maturation | 1.52e-03 | 439 | 40 | 5 | GO:0021700 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.58e-03 | 443 | 40 | 5 | GO:1903311 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.73e-03 | 917 | 40 | 7 | GO:0016071 | |
| GeneOntologyBiologicalProcess | cell maturation | 1.74e-03 | 267 | 40 | 4 | GO:0048469 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.94e-03 | 464 | 40 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid catabolic process | 1.98e-03 | 34 | 40 | 2 | GO:0050995 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 2.22e-03 | 36 | 40 | 2 | GO:0034063 | |
| GeneOntologyBiologicalProcess | germ cell development | 2.29e-03 | 482 | 40 | 5 | GO:0007281 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 2.43e-03 | 1252 | 40 | 8 | GO:0009894 | |
| GeneOntologyBiologicalProcess | peptide hormone processing | 2.87e-03 | 41 | 40 | 2 | GO:0016486 | |
| GeneOntologyBiologicalProcess | nuclear division | 2.97e-03 | 512 | 40 | 5 | GO:0000280 | |
| HumanPheno | Y-linked inheritance | 2.44e-05 | 18 | 17 | 3 | HP:0001450 | |
| HumanPheno | Oligozoospermia | 3.45e-05 | 59 | 17 | 4 | HP:0000798 | |
| MousePheno | absent ovarian follicles | 5.95e-06 | 51 | 33 | 4 | MP:0002777 | |
| Domain | HCAR2/3_rcpt | 3.82e-06 | 2 | 37 | 2 | IPR028017 | |
| Domain | LsmAD | 3.82e-06 | 2 | 37 | 2 | PF06741 | |
| Domain | LsmAD_domain | 3.82e-06 | 2 | 37 | 2 | IPR009604 | |
| Domain | SM_dom_ATX | 3.82e-06 | 2 | 37 | 2 | IPR025852 | |
| Domain | SM-ATX | 3.82e-06 | 2 | 37 | 2 | PF14438 | |
| Domain | LsmAD | 3.82e-06 | 2 | 37 | 2 | SM01272 | |
| Domain | - | 3.65e-05 | 95 | 37 | 4 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 5.76e-05 | 38 | 37 | 3 | PS50025 | |
| Domain | Cadherin_CS | 6.25e-05 | 109 | 37 | 4 | IPR020894 | |
| Domain | Laminin_G_2 | 6.72e-05 | 40 | 37 | 3 | PF02210 | |
| Domain | Cadherin | 7.19e-05 | 113 | 37 | 4 | PF00028 | |
| Domain | CADHERIN_1 | 7.19e-05 | 113 | 37 | 4 | PS00232 | |
| Domain | CADHERIN_2 | 7.44e-05 | 114 | 37 | 4 | PS50268 | |
| Domain | - | 7.44e-05 | 114 | 37 | 4 | 2.60.40.60 | |
| Domain | CA | 7.70e-05 | 115 | 37 | 4 | SM00112 | |
| Domain | Cadherin-like | 7.96e-05 | 116 | 37 | 4 | IPR015919 | |
| Domain | Cadherin | 8.51e-05 | 118 | 37 | 4 | IPR002126 | |
| Domain | LamG | 8.96e-05 | 44 | 37 | 3 | SM00282 | |
| Domain | PAM2 | 1.36e-04 | 9 | 37 | 2 | PF07145 | |
| Domain | Ataxin-2_C | 1.36e-04 | 9 | 37 | 2 | IPR009818 | |
| Domain | Laminin_G | 2.05e-04 | 58 | 37 | 3 | IPR001791 | |
| Domain | Cadherin_N | 2.87e-04 | 65 | 37 | 3 | IPR013164 | |
| Domain | Cadherin_2 | 2.87e-04 | 65 | 37 | 3 | PF08266 | |
| Domain | RRM_1 | 7.40e-04 | 208 | 37 | 4 | PF00076 | |
| Domain | SRCR | 7.83e-04 | 21 | 37 | 2 | PF00530 | |
| Domain | RRM | 8.67e-04 | 217 | 37 | 4 | SM00360 | |
| Domain | ConA-like_dom | 8.97e-04 | 219 | 37 | 4 | IPR013320 | |
| Domain | RRM_dom | 1.02e-03 | 227 | 37 | 4 | IPR000504 | |
| Domain | RRM | 1.08e-03 | 230 | 37 | 4 | PS50102 | |
| Domain | SR | 1.11e-03 | 25 | 37 | 2 | SM00202 | |
| Domain | - | 1.11e-03 | 25 | 37 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 1.20e-03 | 26 | 37 | 2 | PS00420 | |
| Domain | SRCR-like_dom | 1.20e-03 | 26 | 37 | 2 | IPR017448 | |
| Domain | SRCR_2 | 1.20e-03 | 26 | 37 | 2 | PS50287 | |
| Domain | SRCR | 1.30e-03 | 27 | 37 | 2 | IPR001190 | |
| Domain | - | 1.34e-03 | 244 | 37 | 4 | 3.30.70.330 | |
| Domain | ZnF_U1 | 1.50e-03 | 29 | 37 | 2 | SM00451 | |
| Domain | Znf_U1 | 1.50e-03 | 29 | 37 | 2 | IPR003604 | |
| Domain | Nucleotide-bd_a/b_plait | 1.64e-03 | 258 | 37 | 4 | IPR012677 | |
| Domain | Cadherin_tail | 2.43e-03 | 37 | 37 | 2 | PF15974 | |
| Domain | Cadherin_CBD | 2.43e-03 | 37 | 37 | 2 | IPR031904 | |
| Domain | Cadherin_C_2 | 3.13e-03 | 42 | 37 | 2 | PF16492 | |
| Domain | Cadherin_C | 3.13e-03 | 42 | 37 | 2 | IPR032455 | |
| Domain | CUB | 4.24e-03 | 49 | 37 | 2 | PF00431 | |
| Domain | CUB | 4.41e-03 | 50 | 37 | 2 | SM00042 | |
| Domain | - | 4.76e-03 | 52 | 37 | 2 | 2.60.120.290 | |
| Domain | CUB | 4.94e-03 | 53 | 37 | 2 | PS01180 | |
| Domain | CUB_dom | 5.69e-03 | 57 | 37 | 2 | IPR000859 | |
| Pathway | WP_OVARIAN_INFERTILITY | 5.37e-07 | 35 | 27 | 4 | MM15948 | |
| Pathway | WP_MALE_INFERTILITY | 7.23e-06 | 145 | 27 | 5 | M39856 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.36e-04 | 301 | 27 | 5 | MM15983 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 1.50e-12 | 4 | 40 | 4 | 15066457 | |
| Pubmed | 1.50e-12 | 4 | 40 | 4 | 7670487 | ||
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 1.50e-12 | 4 | 40 | 4 | 26232607 | |
| Pubmed | 1.50e-12 | 4 | 40 | 4 | 11694340 | ||
| Pubmed | 1.50e-12 | 4 | 40 | 4 | 9321470 | ||
| Pubmed | 1.50e-12 | 4 | 40 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 1.50e-12 | 4 | 40 | 4 | 11095434 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 1.50e-12 | 4 | 40 | 4 | 11688365 | |
| Pubmed | 1.50e-12 | 4 | 40 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 1.50e-12 | 4 | 40 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 1.50e-12 | 4 | 40 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 1.50e-12 | 4 | 40 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 1.50e-12 | 4 | 40 | 4 | 12801575 | |
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 23298641 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 23579190 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 7.49e-12 | 5 | 40 | 4 | 22223682 | |
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 7.49e-12 | 5 | 40 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 7.49e-12 | 5 | 40 | 4 | 9288969 | |
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 20008336 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 7.49e-12 | 5 | 40 | 4 | 8679003 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 7.49e-12 | 5 | 40 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 7.49e-12 | 5 | 40 | 4 | 8968756 | |
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 7.49e-12 | 5 | 40 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 7.49e-12 | 5 | 40 | 4 | 26411291 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 7.49e-12 | 5 | 40 | 4 | 10903443 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 7.49e-12 | 5 | 40 | 4 | 23223451 | |
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 34985827 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 11804965 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 9143498 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 7.49e-12 | 5 | 40 | 4 | 14648873 | |
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 7.49e-12 | 5 | 40 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 7.49e-12 | 5 | 40 | 4 | 8845845 | |
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 8896558 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 7.49e-12 | 5 | 40 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 7.49e-12 | 5 | 40 | 4 | 19783541 | |
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 22293198 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 17761180 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 19468308 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 9700189 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 7.49e-12 | 5 | 40 | 4 | 12200456 | |
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 11514340 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 21270429 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 11089564 | ||
| Pubmed | 7.49e-12 | 5 | 40 | 4 | 8661148 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 32170089 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 2.25e-11 | 6 | 40 | 4 | 15066460 | |
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 16278232 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 20157580 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 2.25e-11 | 6 | 40 | 4 | 18452650 | |
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 17219433 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 2.25e-11 | 6 | 40 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 2.25e-11 | 6 | 40 | 4 | 16001084 | |
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 32962040 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 2.25e-11 | 6 | 40 | 4 | 1869307 | |
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 11390979 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 24086306 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 27632217 | ||
| Pubmed | 2.25e-11 | 6 | 40 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 2.25e-11 | 6 | 40 | 4 | 14611632 | |
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 2.25e-11 | 6 | 40 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 2.25e-11 | 6 | 40 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 2.25e-11 | 6 | 40 | 4 | 23417416 | |
| Pubmed | 5.23e-11 | 7 | 40 | 4 | 11410654 | ||
| Pubmed | 5.23e-11 | 7 | 40 | 4 | 15081113 | ||
| Pubmed | 5.23e-11 | 7 | 40 | 4 | 22699423 | ||
| Pubmed | 5.23e-11 | 7 | 40 | 4 | 11604102 | ||
| Pubmed | 5.23e-11 | 7 | 40 | 4 | 10857750 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 5.23e-11 | 7 | 40 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 5.23e-11 | 7 | 40 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 5.23e-11 | 7 | 40 | 4 | 16946704 | |
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 10951504 | ||
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 1.05e-10 | 8 | 40 | 4 | 23204224 | |
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 29883445 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 1.05e-10 | 8 | 40 | 4 | 32339196 | |
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 10823932 | ||
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 22621333 | ||
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 32686646 | ||
| Pubmed | 1.05e-10 | 8 | 40 | 4 | 11869379 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.88e-10 | 9 | 40 | 4 | 26378784 | |
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.88e-10 | 9 | 40 | 4 | 16310179 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.88e-10 | 9 | 40 | 4 | 19695304 | |
| Pubmed | 1.88e-10 | 9 | 40 | 4 | 28235998 | ||
| Pubmed | 1.88e-10 | 9 | 40 | 4 | 20159962 | ||
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 10601091 | ||
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 3.13e-10 | 10 | 40 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 3.13e-10 | 10 | 40 | 4 | 38433229 | |
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 9922113 | ||
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 23810942 | ||
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 12837688 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 4.92e-10 | 11 | 40 | 4 | 34401671 | |
| Pubmed | Retinoic acid activates two pathways required for meiosis in mice. | 7.37e-10 | 12 | 40 | 4 | 25102060 | |
| Pubmed | 7.37e-10 | 12 | 40 | 4 | 32054698 | ||
| Pubmed | Germ cell-intrinsic and -extrinsic factors govern meiotic initiation in mouse embryos. | 7.37e-10 | 12 | 40 | 4 | 19074348 | |
| Interaction | DAZL interactions | 2.86e-07 | 145 | 38 | 6 | int:DAZL | |
| Interaction | PCDHGB1 interactions | 1.32e-05 | 77 | 38 | 4 | int:PCDHGB1 | |
| Cytoband | Yq11.223 | 1.36e-06 | 93 | 40 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 1.56e-04 | 311 | 40 | 4 | chrYq11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 2.24e-03 | 298 | 40 | 3 | chr5q31 | |
| Cytoband | 12q24.31 | 2.24e-03 | 80 | 40 | 2 | 12q24.31 | |
| Cytoband | 5q31 | 4.56e-03 | 115 | 40 | 2 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 5.65e-03 | 415 | 40 | 3 | chr12q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p35 | 6.40e-03 | 137 | 40 | 2 | chr1p35 | |
| GeneFamily | Hydroxy-carboxylic acid receptors | 5.50e-06 | 3 | 25 | 2 | 200 | |
| GeneFamily | RNA binding motif containing | 1.95e-04 | 213 | 25 | 4 | 725 | |
| GeneFamily | Clustered protocadherins | 3.51e-03 | 64 | 25 | 2 | 20 | |
| GeneFamily | Fibronectin type III domain containing | 2.04e-02 | 160 | 25 | 2 | 555 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 2.28e-09 | 12 | 40 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 2.28e-09 | 12 | 40 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 4.03e-08 | 23 | 40 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 1.42e-07 | 31 | 40 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 1.84e-07 | 33 | 40 | 4 | MM701 | |
| Coexpression | MADAN_DPPA4_TARGETS | 9.02e-06 | 86 | 40 | 4 | MM1312 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 1.23e-05 | 93 | 40 | 4 | MM1185 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP | THEMIS2 PLA2G7 HAPLN3 HCAR3 HCAR2 ATP13A1 TET3 TENT5A LGALS3BP | 1.71e-05 | 1012 | 40 | 9 | M40868 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | 2.32e-05 | 574 | 40 | 7 | MM820 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 4.41e-05 | 258 | 40 | 5 | M2446 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 5.57e-05 | 271 | 40 | 5 | MM1075 | |
| Coexpression | SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP | 1.47e-04 | 67 | 40 | 3 | M3695 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-07 | 184 | 40 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.83e-07 | 192 | 40 | 5 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-05 | 158 | 40 | 4 | 2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 160 | 40 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 160 | 40 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 174 | 40 | 4 | 6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-05 | 177 | 40 | 4 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.98e-05 | 179 | 40 | 4 | 409364d916c5e7e2291284cc74351d8f8a8447ac | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-05 | 179 | 40 | 4 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.02e-05 | 180 | 40 | 4 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.25e-05 | 185 | 40 | 4 | 8ca1374501eca01d8468130b74d50abfd4329fbe | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-05 | 185 | 40 | 4 | 00a991e63e9ac6de3f48a96e3be6073f90cbb442 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.25e-05 | 185 | 40 | 4 | f8de11dd53b34d36368a2082f24ec1416cb7dbae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.40e-05 | 188 | 40 | 4 | e32d95f8e86111245d7f4b5fd72d2471fe0f1304 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.45e-05 | 189 | 40 | 4 | aac79c41ce7acba722c45c016b2c6997fb772a96 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-05 | 191 | 40 | 4 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 2.60e-05 | 192 | 40 | 4 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.60e-05 | 192 | 40 | 4 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | COVID-19-Myeloid-TRAM2|COVID-19 / Condition, Lineage and Cell class | 2.71e-05 | 194 | 40 | 4 | c5bdf2b58c10dcb09797ddaf46b2e6c80d10399f | |
| ToppCell | COVID-19-Myeloid-TRAM2|Myeloid / Condition, Lineage and Cell class | 2.71e-05 | 194 | 40 | 4 | 4060a60c0271e7397b07993a1ef47b3291bba6e3 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-05 | 194 | 40 | 4 | 44a90be1d2b2ae08f8c523bee65dd1e536ec0f95 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 195 | 40 | 4 | d9bdb37bc562c42fb73fdc3f4150335511b3ef9b | |
| ToppCell | Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.77e-05 | 195 | 40 | 4 | 2af46e87947c16a7c2c367637e606cfbb8a78528 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-05 | 196 | 40 | 4 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | (7)_MNP-(7)_Macrophage|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.82e-05 | 196 | 40 | 4 | 71ec157163278ad259c190051926bf41e4ecef46 | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.82e-05 | 196 | 40 | 4 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-05 | 197 | 40 | 4 | 5a71e859ebe734fc70a056807b07d99fa867c687 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-05 | 197 | 40 | 4 | 07aee25e17dbb71e49f7da9fd9ed2537f4a72d82 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-05 | 197 | 40 | 4 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 198 | 40 | 4 | dbae6a58cb3ce8612755fbdba6194b70b35f258a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 198 | 40 | 4 | 41e8a7894f52f3a5f8f24575b3f6e205429489b2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-05 | 199 | 40 | 4 | 9df2c79904dacf029ec9df1f1cde72d871189a82 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.00e-05 | 199 | 40 | 4 | c684530d4d8073337379c2a24e5e54297fb13691 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-05 | 200 | 40 | 4 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.05e-05 | 200 | 40 | 4 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.05e-05 | 200 | 40 | 4 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.62e-04 | 118 | 40 | 3 | d7dcffc0476a6e471debd83904a6569c6f27a594 | |
| ToppCell | -IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-04 | 128 | 40 | 3 | dab10774bc0532a1664fd8ac2b54cffab01be55a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-04 | 131 | 40 | 3 | 96d300958545714d18e905e860e95469c8ae4efa | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-04 | 144 | 40 | 3 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-04 | 144 | 40 | 3 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-04 | 148 | 40 | 3 | 31a7c2b20970070b14d2b955020320a6f99db547 | |
| ToppCell | Myeloid-F|World / shred on cell class and cell subclass (v4) | 3.54e-04 | 154 | 40 | 3 | 6d53eec4aefe54836bbfd314f28f5e9a24c2d833 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-04 | 156 | 40 | 3 | 6e60e860603a7e8194f437a574ff8e887f6083b8 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 162 | 40 | 3 | 3a1cbfed5a063131d49e3c1584f62b12660ecb36 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-04 | 162 | 40 | 3 | 04b3c38bb27fa369a9ac5b60883f8b058abc5180 | |
| ToppCell | BAL-Severe-cDC_8|Severe / Compartment, Disease Groups and Clusters | 4.25e-04 | 164 | 40 | 3 | e8cbe7e01eca32886eb44e02d5333056b6bebc50 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 165 | 40 | 3 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.33e-04 | 165 | 40 | 3 | 1703d3eb644b3c743ad3c5532b1d29ea010c79c8 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-04 | 166 | 40 | 3 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L6_SST_NPY_(Sst_Chodl)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-04 | 167 | 40 | 3 | 63fefb7af288dbc95ebf6d5e5a71de577b7f3e27 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 168 | 40 | 3 | 100ab6d36592b61f4db9f8cb90c48afac016d679 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.64e-04 | 169 | 40 | 3 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.72e-04 | 170 | 40 | 3 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 171 | 40 | 3 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-04 | 172 | 40 | 3 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-04 | 172 | 40 | 3 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-04 | 172 | 40 | 3 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-04 | 173 | 40 | 3 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | Epithelial-Epithelial-C_(AT2)|Epithelial / shred on cell class and cell subclass (v4) | 4.97e-04 | 173 | 40 | 3 | f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.06e-04 | 174 | 40 | 3 | 68914ec843f58ecff3e6412544a341daf8a01cac | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 5.06e-04 | 174 | 40 | 3 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | 8902c38067f025b094ca9c28c449c32a66eded1c | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | 6bb8fc2959583644f16b22e906af91af62a3a633 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 175 | 40 | 3 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-04 | 176 | 40 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.23e-04 | 176 | 40 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-04 | 177 | 40 | 3 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | droplet-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 177 | 40 | 3 | a5b54792ef948a1e1de66301a60e051250189f59 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.40e-04 | 178 | 40 | 3 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 5.49e-04 | 179 | 40 | 3 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-04 | 179 | 40 | 3 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | COPD-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 5.49e-04 | 179 | 40 | 3 | e816dd846a6918ec143b57a380c3a47ed073b66e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-04 | 180 | 40 | 3 | 7af90f0e7ca001bf1fe5c860ee54c4cc8eb483bf | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Dendritic|GI_large-bowel / Manually curated celltypes from each tissue | 5.58e-04 | 180 | 40 | 3 | 400f48aa2851d89bf3b60d721bc0f635f3ad86eb | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-04 | 180 | 40 | 3 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Dendritic-DC2|GI_large-bowel / Manually curated celltypes from each tissue | 5.58e-04 | 180 | 40 | 3 | d4ebe67a2735e244c08b238320bbb441ca88ee6f | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.67e-04 | 181 | 40 | 3 | 08bc6fe2a11d31a7e5e4a4552b04c0ebc2aefc59 | |
| ToppCell | facs-Heart-LA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-04 | 182 | 40 | 3 | 47b747722766dbcc6a73673e99ee5f938b82b890 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 183 | 40 | 3 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 183 | 40 | 3 | ddc45fb591ba0ce3fa05c08051d58286a89ef835 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-04 | 183 | 40 | 3 | a253ad65673fce6cb453e709cb235ce7cbfa18b7 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-CXCL9+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.85e-04 | 183 | 40 | 3 | 99a36e9c74346b619b3b87d8d6bbf9b4b797c821 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-04 | 183 | 40 | 3 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-04 | 183 | 40 | 3 | 92d5a61b57851090eba558f19e2a7010043eff81 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.85e-04 | 183 | 40 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | 10706441e7695212f95689414f31e8082b5eaf0a | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-04 | 184 | 40 | 3 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.95e-04 | 184 | 40 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 184 | 40 | 3 | 4bb0976a75126ad2b3deb5d2229f0716fafe200e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-04 | 185 | 40 | 3 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.04e-04 | 185 | 40 | 3 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.04e-04 | 185 | 40 | 3 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 185 | 40 | 3 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-04 | 185 | 40 | 3 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| Drug | boron trichloride | 1.22e-10 | 6 | 40 | 4 | CID000025135 | |
| Drug | molybdenum disulfide | 1.18e-08 | 43 | 40 | 5 | CID000014823 | |
| Drug | desmethylazelastine | 1.46e-08 | 16 | 40 | 4 | CID000162558 | |
| Drug | dazmegrel | 3.11e-08 | 19 | 40 | 4 | CID000053555 | |
| Drug | YM 026 | 3.11e-08 | 19 | 40 | 4 | CID000004443 | |
| Drug | AZFd | 7.06e-08 | 23 | 40 | 4 | CID000196489 | |
| Drug | dansylaziridine | 7.06e-08 | 23 | 40 | 4 | CID000104008 | |
| Drug | d-gluconhydroximo-1,5-lactam | 2.48e-07 | 31 | 40 | 4 | CID000003479 | |
| Drug | Vistar | 4.62e-07 | 36 | 40 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 4.62e-07 | 36 | 40 | 4 | CID000001649 | |
| Drug | BW755C | 5.99e-07 | 93 | 40 | 5 | CID000047795 | |
| Drug | bipy | 7.40e-07 | 97 | 40 | 5 | CID000001474 | |
| Drug | 2-chlorodideoxyadenosine | 9.59e-07 | 43 | 40 | 4 | CID000072194 | |
| Drug | propham | 1.05e-06 | 44 | 40 | 4 | CID000024685 | |
| Drug | TXB2 (thromboxane B2 | 1.95e-06 | 118 | 40 | 5 | CID000005461 | |
| Drug | ridogrel | 2.08e-06 | 52 | 40 | 4 | CID005362391 | |
| Drug | azafagomine | 3.02e-06 | 57 | 40 | 4 | CID011957435 | |
| Drug | NSC56408 | 4.23e-06 | 62 | 40 | 4 | CID000005604 | |
| Drug | kt S | 5.44e-06 | 66 | 40 | 4 | CID006399216 | |
| Drug | azelastine | 8.60e-06 | 74 | 40 | 4 | CID000002267 | |
| Drug | p11-13 | 9.07e-06 | 75 | 40 | 4 | CID000015759 | |
| Drug | intruder | 9.91e-06 | 24 | 40 | 3 | CID000213021 | |
| Drug | neocarzinostatin chromophore | 1.04e-05 | 288 | 40 | 6 | CID000447545 | |
| Drug | Niacin | 1.80e-05 | 4 | 40 | 2 | DB00627 | |
| Drug | niacin | 2.43e-05 | 198 | 40 | 5 | CID000000937 | |
| Drug | acifran | 3.00e-05 | 5 | 40 | 2 | ctd:C036804 | |
| Drug | thromboxane | 4.29e-05 | 223 | 40 | 5 | CID000114873 | |
| Drug | carbonyl sulfide | 5.07e-05 | 116 | 40 | 4 | CID000010039 | |
| Drug | 4-chlorobenzylamine | 8.37e-05 | 8 | 40 | 2 | CID000066036 | |
| Drug | Nicotinic Acids | 8.37e-05 | 8 | 40 | 2 | ctd:D009539 | |
| Drug | McN-A-343 | 9.30e-05 | 50 | 40 | 3 | CID000004022 | |
| Drug | Niacin | 1.03e-04 | 139 | 40 | 4 | ctd:D009525 | |
| Drug | acifran | 1.08e-04 | 9 | 40 | 2 | CID000051576 | |
| Drug | Fish Oils | 1.34e-04 | 149 | 40 | 4 | ctd:D005395 | |
| Drug | NSC624746 | 1.38e-04 | 57 | 40 | 3 | CID000107640 | |
| Disease | Male sterility due to Y-chromosome deletions | 1.82e-10 | 8 | 39 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 1.82e-10 | 8 | 39 | 4 | C1507149 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.18e-06 | 16 | 39 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.18e-06 | 16 | 39 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.18e-06 | 16 | 39 | 3 | cv:C1839071 | |
| Disease | spinocerebellar ataxia type 2 (implicated_via_orthology) | 1.70e-06 | 2 | 39 | 2 | DOID:0050955 (implicated_via_orthology) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.11e-04 | 12 | 39 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.15e-04 | 71 | 39 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | factor VIII measurement, Ischemic stroke | 2.87e-04 | 19 | 39 | 2 | EFO_0004630, HP_0002140 | |
| Disease | azoospermia (implicated_via_orthology) | 5.85e-04 | 27 | 39 | 2 | DOID:14227 (implicated_via_orthology) | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 7.23e-04 | 30 | 39 | 2 | EFO_0004629, HP_0002140 | |
| Disease | waist-hip ratio | 1.01e-03 | 1226 | 39 | 7 | EFO_0004343 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.35e-03 | 41 | 39 | 2 | DOID:10584 (is_implicated_in) | |
| Disease | blood phosphate measurement | 1.58e-03 | 174 | 39 | 3 | EFO_0010972 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.63e-03 | 45 | 39 | 2 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.63e-03 | 45 | 39 | 2 | EFO_0004623, EFO_0004792 | |
| Disease | cognitive inhibition measurement | 2.00e-03 | 50 | 39 | 2 | EFO_0007969 | |
| Disease | wellbeing measurement | 2.08e-03 | 692 | 39 | 5 | EFO_0007869 | |
| Disease | birth weight, parental genotype effect measurement | 2.09e-03 | 192 | 39 | 3 | EFO_0004344, EFO_0005939 | |
| Disease | Ischemic stroke, fibrinogen measurement | 2.42e-03 | 55 | 39 | 2 | EFO_0004623, HP_0002140 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 2.51e-03 | 56 | 39 | 2 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Psoriasis | 2.59e-03 | 57 | 39 | 2 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 2.59e-03 | 57 | 39 | 2 | C0030246 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NFTFNVKFYPPDPAQ | 281 | P11171 | |
| APNYYPNSFGAPEQQ | 401 | P04040 | |
| TFTSPCYPNDYPNSQ | 51 | Q86SQ4 | |
| PVAFPVGNAFSYYQS | 191 | Q9HD20 | |
| DINDNSPVFYPVQYF | 681 | Q6V0I7 | |
| NTNPENPYAGFFEYV | 646 | Q9C0A0 | |
| NYQAFPAYPNSPFQV | 236 | Q13117 | |
| PAYPNSPFQVATGYQ | 241 | Q13117 | |
| SPFQVATGYQFPVYN | 246 | Q13117 | |
| QAFPAYPNSPFQVAT | 286 | Q13117 | |
| YPNSPFQVATGYQFP | 291 | Q13117 | |
| VYNYQAFPAYPNSPV | 306 | Q13117 | |
| YNYQAFPAYPNSPVQ | 331 | Q13117 | |
| FPAYPNSPVQVTTGY | 336 | Q13117 | |
| NYQAFPAYPSSPFQV | 356 | Q13117 | |
| LPVYNYQAFPAYPSS | 376 | Q13117 | |
| YQAFPAYPSSPFQVT | 381 | Q13117 | |
| VYNYQAFPAYPSSPF | 426 | Q13117 | |
| YNYQAFPAYPSSPFQ | 451 | Q13117 | |
| NYQAFPAYPSSPFQV | 476 | Q13117 | |
| YQAFPAYPNSAVQVT | 501 | Q13117 | |
| NYQAFPAYPNSPFQV | 236 | Q9NR90 | |
| PAYPNSPFQVATGYQ | 241 | Q9NR90 | |
| SPFQVATGYQFPVYN | 246 | Q9NR90 | |
| QAFPAYPNSPFQVAT | 286 | Q9NR90 | |
| YPNSPFQVATGYQFP | 291 | Q9NR90 | |
| VYNYQAFPAYPNSPV | 306 | Q9NR90 | |
| YNYQAFPAYPNSPFQ | 331 | Q9NR90 | |
| FPAYPNSPFQVATGY | 336 | Q9NR90 | |
| NSPFQVATGYQFPVY | 341 | Q9NR90 | |
| NYQAFPAYPNSPVQV | 356 | Q9NR90 | |
| YQAFPAYPNSPFQVA | 381 | Q9NR90 | |
| AYPNSPFQVATGYQF | 386 | Q9NR90 | |
| ATPYSSYIPYNPQQF | 781 | Q8WWM7 | |
| NDNPPVFPQASYSAY | 446 | O60330 | |
| VVFPYQSPNGRYQFN | 166 | Q96S86 | |
| YNPQFEYANPALPSV | 261 | Q8NCT3 | |
| YPYQSFQTPQHPSFL | 456 | Q08380 | |
| PVVYYFSSPSFPNFF | 291 | Q8TDS4 | |
| PPAYSTQYVAYSPQQ | 1031 | Q99700 | |
| QFPYPQAPFVSQYEN | 176 | Q08397 | |
| NDNPPAFSQASYSVY | 446 | Q9Y5G4 | |
| FSPFLYYQSQELPNG | 216 | A8MUH7 | |
| PLYYQPGNDQPVSFN | 326 | Q6ZU69 | |
| PLYYQPGNDQPVSFN | 56 | Q63HN1 | |
| NSPVFTHNEYNFYVP | 566 | Q9BZA7 | |
| PQPLFFINSEYFQYP | 311 | Q13093 | |
| FPDNYNSPTPYKIQY | 1056 | Q13332 | |
| NYQAFPAYPNSPFQV | 566 | Q9NQZ3 | |
| PAYPNSPFQVATGYQ | 571 | Q9NQZ3 | |
| SPFQVATGYQFPVYN | 576 | Q9NQZ3 | |
| QAFPAYPNSPFQVAT | 616 | Q9NQZ3 | |
| YPNSPFQVATGYQFP | 621 | Q9NQZ3 | |
| VYNYQAFPAYPNSPV | 636 | Q9NQZ3 | |
| YNYQAFPAYPSSPFQ | 661 | Q9NQZ3 | |
| NYQAFPAYPNSAVQV | 686 | Q9NQZ3 | |
| YSPVQLPSYAPENYN | 51 | A8K830 | |
| FAAQNLPNGYPRYPS | 141 | Q8WU20 | |
| NKYNQTHYDFDNPPP | 656 | Q8WUQ7 | |
| NYQAFPAYPNSPFQV | 401 | Q86SG3 | |
| PAYPNSPFQVATGYQ | 406 | Q86SG3 | |
| SPFQVATGYQFPVYN | 411 | Q86SG3 | |
| QAFPAYPNSPFQVAT | 451 | Q86SG3 | |
| YPNSPFQVATGYQFP | 456 | Q86SG3 | |
| VYNYQAFPAYPNSPV | 471 | Q86SG3 | |
| YNYQAFPAYPSSPFQ | 496 | Q86SG3 | |
| NYQAFPAYPNSAVQV | 521 | Q86SG3 | |
| TFSSPSYPAYYPNNA | 1776 | Q9UGM3 | |
| NYSPFRTPYTPNSQY | 361 | Q9ULU4 | |
| NAYGTPFYPSQPVYQ | 106 | O43432 | |
| PNYRPGYNNFYNTPS | 461 | O75445 | |
| PVVYYFSSPSFPNFF | 291 | P49019 | |
| LRTNPYPPQQYSSFQ | 381 | Q14190 | |
| QPSGFLVSPQYFAYP | 206 | A0PJX4 | |
| GFYHPFPTPYSNTFQ | 121 | Q93073 | |
| NYNNFYRFLPTAPPN | 196 | Q8TBZ0 | |
| QFQQPQFLFPFYIPG | 1686 | Q86UP3 | |
| NFQGYFTPLNTPQSY | 76 | Q5TEJ8 | |
| LPNENPPSYYSIFNY | 246 | Q8WVE6 | |
| YYGFPSSNPVFPSQF | 1286 | O43151 | |
| QAYTPASPQPFYGNN | 71 | Q969M3 | |
| PPPATTQNYQDSYSY | 131 | Q96KR1 | |
| PNVANVTCYYQPAPY | 396 | Q96IP4 |